These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25988046)

  • 1. Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction.
    Li M; Chan D; Li BT; Pavlakis N; Kneebone A; Bailey D; Clarke S
    Oxf Med Case Reports; 2014 Sep; 2014(6):105-6. PubMed ID: 25988046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First case on fluorodeoxyglucose positron emission tomography/computerized tomography of a distant skip metastases to parotid node from esophageal adenocarcinoma.
    Militano V; Muthu S; Farooq N; Sajjan R
    World J Nucl Med; 2018; 17(4):302-304. PubMed ID: 30505232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
    de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
    Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinoma.
    Di Fiore F; Blondin V; Hitzel A; Edet-Sanson A; Benyoucef A; Huet E; Vera P; Michel P
    Dig Liver Dis; 2012 Oct; 44(10):875-9. PubMed ID: 22883219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma.
    Geh JI; Glynne-Jones R; Kwok QS; Banerji U; Livingstone JI; Townsend ER; Harrison RA; Mitchell IC
    Clin Oncol (R Coll Radiol); 2000; 12(3):182-7. PubMed ID: 10942336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review.
    Kayani B; Zacharakis E; Ahmed K; Hanna GB
    Eur J Surg Oncol; 2011 Sep; 37(9):747-53. PubMed ID: 21839394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers.
    Mirza A; Galloway S
    Surg Endosc; 2016 Jul; 30(7):2690-6. PubMed ID: 26487234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siewert type I and II oesophageal adenocarcinoma: sensitivity/specificity of computed tomography, positron emission tomography and endoscopic ultrasound for assessment of lymph node metastases in groups of thoracic and abdominal lymph node stations.
    Lopci E; Kauppi J; Lugaresi M; Mattioli B; Daddi N; Fortunato F; Rasanen J; Mattioli S
    Interact Cardiovasc Thorac Surg; 2019 Apr; 28(4):518-525. PubMed ID: 30496443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.
    van de Ven C; De Leyn P; Coosemans W; Van Raemdonck D; Lerut T
    Eur J Cardiothorac Surg; 1999 Jun; 15(6):769-73. PubMed ID: 10431857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report.
    Tanaka T; Arigami T; Uenosono Y; Yanagita S; Matsushita D; Okubo K; Kijima T; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Ishigami S; Natsugoe S
    Surg Case Rep; 2020 Jan; 6(1):13. PubMed ID: 31919764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Node-Negative Esophageal Cancer With Short-Interval Isolated Metastasis to the Gallbladder: A Case Report.
    Hart CM; Haisley KR; Lanciault C; Dolan JP
    Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):115-117. PubMed ID: 28683987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction.
    Hulshof MC; van Laarhoven HW
    Best Pract Res Clin Gastroenterol; 2016 Aug; 30(4):551-63. PubMed ID: 27644904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-metastasized oesophageal cancer].
    Biere SS; van Weyenberg SJ; Verheul HM; Mulder CJ; Cuesta MA; van der Peet DL
    Ned Tijdschr Geneeskd; 2010; 154(8):A820. PubMed ID: 21108861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative staging of gastro-oesophageal junction carcinoma: comparison of endoscopic ultrasound and computed tomography.
    Holden A; Mendelson R; Edmunds S
    Australas Radiol; 1996 Aug; 40(3):206-12. PubMed ID: 8826718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.
    Takeshita N; Fukunaga T; Kimura M; Sugamoto Y; Tasaki K; Hoshino I; Ota T; Maruyama T; Tamachi T; Hosokawa T; Asai Y; Matsubara H
    World J Gastroenterol; 2015 Nov; 21(44):12722-8. PubMed ID: 26640350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Kang YK; Boku N; Satoh T; Ryu MH; Chao Y; Kato K; Chung HC; Chen JS; Muro K; Kang WK; Yeh KH; Yoshikawa T; Oh SC; Bai LY; Tamura T; Lee KW; Hamamoto Y; Kim JG; Chin K; Oh DY; Minashi K; Cho JY; Tsuda M; Chen LT
    Lancet; 2017 Dec; 390(10111):2461-2471. PubMed ID: 28993052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.